Feb 21 (Reuters) - Genetic testing firm 23andMe ME.O Chief Executive Officer Anne Wojcicki and investment firm New Mountain Capital have submitted a proposal to take the company private, according to a regulatory filing on Friday.
Both parties have jointly made an offer to buy the company for $2.53 per share, a deal that would value the company at $67.9 million.
Last month, 23andMe had said it was exploring strategic alternatives, including a possible sale, in light of significant doubts about its ability to sustain operations.
Wojcicki, who has been trying to take the company private since April, has faced a tough challenge after independent directors of 23andMe resigned in September, unsatisfied with the take-private offer they received.
In July, the CEO and co-founder proposed buying all outstanding shares of the firm not already owned by her or affiliated entities for 40 cents each.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
((Christy.Santhosh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。